Technology
Health
Pharmaceutical

Novan

$2.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-3.15%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Novan and other stocks, options, ETFs, and crypto commission-free!

About NOVN

Novan, Inc. Common Stock, also called Novan, is a biotechnology company, which engages in leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Read More Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.

Employees
48
Headquarters
Morrisville, North Carolina
Founded
2006
Market Cap
74.56M
Price-Earnings Ratio
Dividend Yield
Average Volume
59.08K
High Today
$2.88
Low Today
$2.77
Open Price
$2.83
Volume
34.65K
52 Week High
$3.24
52 Week Low
$0.65

Collections

Technology
Health
Pharmaceutical
Biotechnology
Medical
2016 IPO
US
North America

NOVN Earnings

-$0.51
-$0.25
$0.02
$0.28
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.27 per share
Actual
Expected Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.